Literature DB >> 24707023

Upper endoscopy in children: do symptoms predict positive findings?

Baraa Alabd Alrazzak1, Tarek Husien, Deborah L Preston, Yoram Elitsur.   

Abstract

Upper endoscopy (esophagogastroduodenoscopy or EGD) is an important diagnostic tool for many gastrointestinal symptoms. In recent years, the number of EGDs has increased dramatically. Unfortunately, the rate of negative (normal) EGD in children is high, approximating 50% of all procedures. To decrease the cost of EGD procedures, it is important to assess which clinical symptom would detect positive findings. This information may also be valuable in improving the referral practices of the primary care physicians for EGD. In a retrospective study, we investigated the pathological yield of the first EGD in children referred for various symptoms. Abdominal pain was the most common referral symptom and the best predictor of positive EGD, reaching an accuracy level of 79.9%. All other investigated symptoms had less than 50% accuracy. We concluded that most gastrointestinal symptoms in children have a poor predictive value for positive EGD. A cost-benefit analysis of EGD in children is needed.

Entities:  

Keywords:  EGD; children; referral symptoms; upper endoscopy

Mesh:

Year:  2014        PMID: 24707023     DOI: 10.1177/0009922814528034

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  3 in total

1.  The diagnostic yield of upper endoscopy procedures in children- is it cost effective?

Authors:  Yoram Elitsur
Journal:  Curr Gastroenterol Rep       Date:  2014

Review 2.  Efficiency of upper gastrointestinal endoscopy in pediatric surgical practice.

Authors:  Abdulkerim Temiz
Journal:  World J Clin Pediatr       Date:  2015-11-08

3.  Diagnostic yield and appropriate indication of upper endoscopy in Jordanian children.

Authors:  Eyad Altamimi; Yousef Odeh; Tuka Al-Quraan; Elmi Mohamed; Naif Rawabdeh
Journal:  BMC Pediatr       Date:  2021-01-05       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.